Correlation Between Verrica Pharmaceuticals and Tango Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Tango Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Tango Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Tango Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Tango Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Tango Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Tango Therapeutics.

Diversification Opportunities for Verrica Pharmaceuticals and Tango Therapeutics

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Verrica and Tango is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Tango Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tango Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Tango Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tango Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Tango Therapeutics go up and down completely randomly.

Pair Corralation between Verrica Pharmaceuticals and Tango Therapeutics

Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Tango Therapeutics. In addition to that, Verrica Pharmaceuticals is 1.54 times more volatile than Tango Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Tango Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  752.00  in Tango Therapeutics on September 23, 2024 and sell it today you would lose (442.00) from holding Tango Therapeutics or give up 58.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Verrica Pharmaceuticals  vs.  Tango Therapeutics

 Performance 
       Timeline  
Verrica Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verrica Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Tango Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tango Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Verrica Pharmaceuticals and Tango Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verrica Pharmaceuticals and Tango Therapeutics

The main advantage of trading using opposite Verrica Pharmaceuticals and Tango Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Tango Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tango Therapeutics will offset losses from the drop in Tango Therapeutics' long position.
The idea behind Verrica Pharmaceuticals and Tango Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency